Skip to main content
SpringerLink
Log in

Myocardial Effects of Dihydropyridines in Patients

  • Conference paper
Cardiovascular Effects of Dihydropyridine-Type Calcium Antagonists and Agonists

Part of the book series: Bayer-Symposium ((BAYER-SYMP,volume 9))

  • 76 Accesses

Abstract

Of the many possible applications of the dihydropyridines in clinical cardiology, I have chosen to talk only about conditions in which acute cardiac ischemia is present. This the more so since Lichtlen (1984) and Buhler (1984), respectively, will talk about the effects of these compounds on the coronary vasculature and on the peripheral vasculature in hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Brower RW, Jong JW de, Haalebos M, Simoons ML, Bos A vd, Jong DS de, Bos E, Hugenholtz PG (1982) Evaluation of cardioplegia in coronary artery bypass graft surgery. In: Just H, Tschirkov A, Schlosser V (eds) Kalziumantagonisten zur Kardioplegie und Myokardprotektion in der offenen Herzchirurgie. Thieme, Stuttgart, p 69.

    Google Scholar 

  • Buckberg GD, Olinger GN, Mulder DG, Maloney Jr JV (1975) Depressed postoperative cardiac performance. Prevention by adequate protection during cardiopulmonary bypass. J Thorac Cardiovasc Surg 70:974.

    PubMed  CAS  Google Scholar 

  • Buehler H (1984) In these proceedings.

    Google Scholar 

  • Churchill W (1948) The gathering storm. Publication Company, Boston.

    Google Scholar 

  • Clark RE, Magovern GJ, Christlieb, IY, Boe S (1983) Nifedipine cardioplegia experience: results of a 3-year cooperative clinical study. Ann Thorac Surg 36:654.

    Article  PubMed  CAS  Google Scholar 

  • Clark RE, Christlieb IY, Henry PD, Fisher AE, Nora JD, Williamson JR, Sobel BE (1979) Nifedipine: a myocardial protective agent. Am J Cardiol 44:825.

    Article  PubMed  CAS  Google Scholar 

  • Dargie HJ, Lynch PG, Krikler DM, Harris L, Kirkler S (1981) Nifedipine and propranolol: a beneficial drug interaction. Am J Med 71:676.

    Article  PubMed  CAS  Google Scholar 

  • Flameng W, Borgers M, Van der Vusse GJ; Demeyere R, Vandermeersch E, Thone F, Suy R (1983) Cardioprotective effects of lidoflazine in extensive aorta-coronary bypass grafting. J Thorac Cardiovasc Surg 85:758.

    PubMed  CAS  Google Scholar 

  • Fleckenstein A (1983) Calcium antagonism in heart and smooth muscle. Wiley, New York.

    Google Scholar 

  • Hauf E (1984) Personal communications.

    Google Scholar 

  • Hugenholtz PG, Michels HR, Serruys PW, Brower RW (1981) Nifedipine in the treatment of unstable angina, coronary artery spasm and myocardial ischemia. Am J Cardiol 47:163.

    Article  PubMed  CAS  Google Scholar 

  • Hugenholtz PG, Michels HR, Serruys PW, Simoons ML (1982) What is preferable in unstable angina, beta-blockade or calcium inhibition? Hart Bull 13:171.

    Google Scholar 

  • Hugenholtz PG, Verdouw PD, Jong JW de, Serruys PW (1983) Nifedipine for angina and acute myocardial ischaemia. Postgrad Med J (Suppl 2) 59:40.

    CAS  Google Scholar 

  • Jennings RB, Ganote CE, Reimer KA (1975) Ischemic tissue injury. Am J Pathol 81:179.

    PubMed  CAS  Google Scholar 

  • Jong JW de (1985) Calcium antagonisten en cardioplegie. Hart Bull 16:4.

    Google Scholar 

  • Jong JW de, Harmsen E, Tombe PP de, Keijzer E (1982) Nifedipine reduces adenine nucleotide breakdown in ischemic rat heart. Eur J Pharmacol 81:89.

    Article  PubMed  Google Scholar 

  • Jong JW de, Harmsen E, Tombe PP de, Keijzer E (1983) Energy conservation in ischemic rat heart by nifedipine plus propranolol. Eur Heart J (Supp C) 4:25.

    Google Scholar 

  • Jong JW de, Huizer T, Tijssen JGB (1984) Energy conservation by nisoldipine in ischaemic heart. Br J Pharmacol 83:943.

    PubMed  Google Scholar 

  • Lange LG, Sobel BE (1982) Pharmacological salvage of myocardium. Ann Rev Pharmacol Toxicol 22:115.

    Article  CAS  Google Scholar 

  • Lichtlen P (1984) In these proceedings.

    Google Scholar 

  • Muller JE, Morrison J, Stone PH, Rude RE, Rosner B, Roberts R, Pearle DL, Turi ZG, Schneider JF, Serfas DH, Tate C, Scheiner E, Sobel BE, Hennekens CH; Braunwald E (1984) Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double blind, placebo-controlled comparison. Circulation 69:740.

    Article  PubMed  CAS  Google Scholar 

  • Muller JE, Turi ZG, Pearle DL, Schneider JF, Serfas DH, Morrison J, Stone PH, Rude RE, Rosner B, Sobel BE, Tate C, Scheiner E, Roberts R, Hennekens CH, Braunwald E (1984) Nifedipine and conventional therapy for unstable angina pectoris: a randomized double blind comparison. Circulation 69:728.

    Article  PubMed  CAS  Google Scholar 

  • Nayler WG (1984) In these proceedings.

    Google Scholar 

  • Nayler WG, Poole-Wilson P (1981) Calcium antagonists: definition and mode of action. Bas Res Cardiol 76:1.

    Article  CAS  Google Scholar 

  • Opie LH (1984) Calcium antagonists and cardiovascular disease. Raven Press, New York.

    Google Scholar 

  • Parratt JR (1983) Pharmacological agents to aid the clinician in combating myocardial ischemia. Eur Hear J(Suppl D) 4:91.

    CAS  Google Scholar 

  • Saxena PR (1983) Beta-adrenoceptor antagonists and blood flow to the jeopardized myocardium. Eur Heart J (Suppl D) 4:101.

    CAS  Google Scholar 

  • Schaper W (1983) Natural defense mechanisms during ischemia. Eur Heart J (Suppl D) 4:73.

    Google Scholar 

  • Schmutzler H (1981) Possibilities and perspectives of combination therapy. Adalat and betablockers. In: Coronary heart disease — calcium antagonist Adalat, a worldwide success. Bayer, Leverkusen, p 87.

    Google Scholar 

  • Serruys PW, Brower RW, Katen HJ ten, Meester GT (1980) Recovery from circulatory depression after coronary artery bypass surgery. Eur Surg Res 12:369.

    Article  PubMed  CAS  Google Scholar 

  • Serruys PW, Wijns W, Brand M vd, Meij S, Slager C, Schuurbiers JCH, Hugenholtz PG, Brower RW (1984a) Left ventricular performance, regional blood flow, wall motion, and lactate metabolism during transluminal angioplasty. Circulation 70:25.

    Article  PubMed  CAS  Google Scholar 

  • Serruys PW, Wijns W, Zeegers E, Brand MD, Feyter P de, Jong JW de (1984b) Myocardial release of hypoxanthine and lactate during PTCA: a quickly reversible phenomenon. Circulation (Suppl 2) 70:11–299 (Abstr).

    Article  Google Scholar 

  • Serruys PW, Wijns W, Grimm J, Slager CJ, Hess OM (1984 c) Effects of repeated transluminal occlusions during angioplasty on global and regional left ventricular chamber stiffness. Circulation (Suppl 2) 70:11–348 (Abstr).

    Article  Google Scholar 

  • Spencer FC (1983) Intellectual creativity in thoracic surgeons. J Thorac Cardiovasc Surg 86:163.

    PubMed  CAS  Google Scholar 

  • Stone PH, Antman EM (1983) Calcium channel blocking agents in the treatment of cardiovascular disorders. Futura Publishing, Mount Kisco, New York.

    Google Scholar 

  • Vanhaleweyk GLJ, Serruys PW, Hugenholtz PG (1983) Antianginal electrophysiologic and hemodynamic effects of combined beta-blocker/calciumantagonist therapy. Eur Heart J (Suppl D) 4:117.

    Google Scholar 

  • Verdouw PD, Hartog JM, Cate FJ ten, Schamhardt HC, Bastiaans OL, Bremen RH van, Serruys PW, Hugenholtz PG (1981) Effects of nifedipine on the recovery of regional myocardial performance during reperfusion of ischemic myocardium. Prog Pharmacol 4:91.

    CAS  Google Scholar 

  • Verdouw PD, Wolffenbuttel BHR, Cate FJ ten (1983) Nifedipine with and without propranolol in the treatment of myocardial ischemia: effect on ventricular arrhythmias and recovery of regional wall function. Eur Heart J (Suppl C) 4:101.

    CAS  Google Scholar 

  • Vusse GJ van der, Coumans WA, Veen E vd, Drake AJ, Flameng W, Suy R (1984) ATP, creatine phosphate and glycogen content in human myocardial biopsies: markers for the efficacy of cardioprotection during aorto-coronary bypass surgery. Vasc Surg 18:127.

    Google Scholar 

  • Wolffenbuttel BHR, Verdouw PD (1983) Nifedipine and myocardial performance in the presence and absence of beta-blockade with propranolol. Arch Int Pharmacol Ther 266:83.

    CAS  Google Scholar 

  • Yasue H, Touyama M, Kato H, Tanaka S, Akiyama F (1976) Prinzmetal’s variant form of angina as a manifestation of alpha-adrenergic receptor-mediated coronary artery spasm: documentation by coronary arteriography. Am Heart J 91:149.

    Article  Google Scholar 

  • Yasue H, Omote S, Takizawa A, Nagao M, Miwa K, Tanaka S (1979) Circadian variation of exercise capacity in patients with Prinzmetal’s variant angina: role of exercise induced coronary arterial spasm. Circulation 59:938.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. P. G. Hugenholtz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. W. de Jong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. W. Serruys
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Physiologisches Institut, Universität Freiburg, Hermann-Herder-Straße 7, D-7800, Freiburg i. Br., Germany

    Albrecht Fleckenstein

  2. Department of Pharmacology, University of Miami School of Medicine, P.O. Box 016189, Miami, FL, 33101, USA

    Cornelius Van Breemen D.V.M., Ph.D.

  3. Abteilung Herz-Kreislauf-Pharmakologie II, Bayer AG, Institut für Pharmakologie, Postfach 10 1709, D-5600, Wuppertal 1, Germany

    Rainer Gross

  4. Bayer AG, Institut für Pharmakologie, Postfach 10 1709, D-5600, Wuppertal 1, Germany

    Friedrich Hoffmeister

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Hugenholtz, P.G., de Jong, J.W., Serruys, P.W. (1985). Myocardial Effects of Dihydropyridines in Patients. In: Fleckenstein, A., Van Breemen, C., Gross, R., Hoffmeister, F. (eds) Cardiovascular Effects of Dihydropyridine-Type Calcium Antagonists and Agonists. Bayer-Symposium, vol 9. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70499-4_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70499-4_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-70501-4

  • Online ISBN: 978-3-642-70499-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation